Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022

"Declaration of Interests: In the past 3 years, SLB [Simon L. Bacon] has received consultancy and speaker fees from Resplipus, an investigator-generated educational grant from Moderna, and has served on advisory boards for Bayer, Sanofi, Respiplus, and Sojecci, none of which are related to the current Article. All other authors declare no competing interests.

Acknowledgements: The development and continued updating of this living evidence synthesis has been funded by the Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada."